FIRST NEW YORK SECURITIES LLC /NY - GALECTIN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

GALECTIN THERAPEUTICS INC's ticker is GALTW and the CUSIP is 363225111. A total of 4 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
FIRST NEW YORK SECURITIES LLC /NY ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2014$470,000
+389.6%
46,100
+131.7%
0.23%
+298.3%
Q4 2013$96,000
+108.7%
19,900
+134.1%
0.06%
+222.2%
Q3 2013$46,000
-51.1%
8,500
-88.6%
0.02%
-48.6%
Q2 2013$94,000–74,255–0.04%–
 Download
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 80,000$1,225,0000.28%
FIRST NEW YORK SECURITIES LLC /NY 46,100$470,0000.23%
MILLENNIUM MANAGEMENT LLC 656,600$6,697,0000.02%
Neuberger Berman Group LLC 129,300$1,319,0000.00%
Tower Research Capital LLC (TRC) 740$8,0000.00%
Citadel Advisors 300$3,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders